(NASDAQ: CRON) Cronos Group's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 31.5%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.64%.
Cronos Group's earnings in 2025 is $41,080,000.On average, 2 Wall Street analysts forecast CRON's earnings for 2025 to be $1,912,654, with the lowest CRON earnings forecast at -$15,301,231, and the highest CRON earnings forecast at $19,126,539.
In 2026, CRON is forecast to generate $30,602,462 in earnings, with the lowest earnings forecast at $30,602,462 and the highest earnings forecast at $30,602,462.